批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2009/12/03 |
SUPPL-11(补充) |
Approval |
Labeling |
|
|
|
2009/04/17 |
SUPPL-10(补充) |
Approval |
Labeling |
|
|
|
2000/09/05 |
SUPPL-8(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1995/06/15 |
SUPPL-7(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1995/06/15 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1994/07/06 |
SUPPL-4(补充) |
Approval |
Labeling |
|
|
|
1993/10/04 |
SUPPL-5(补充) |
Approval |
Labeling |
|
|
|
1988/03/18 |
SUPPL-3(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1979/12/11 |
ORIG-1(原始申请) |
Approval |
|
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:NYSTATIN 剂型/给药途径:CREAM;TOPICAL 规格:100,000 UNITS/GM 治疗等效代码:AT
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
061966 |
001 |
ANDA |
NYSTATIN |
NYSTATIN |
CREAM;TOPICAL |
100,000 UNITS/GM |
Prescription |
No |
No |
AT |
Approved Prior to Jan 1, 1982
|
COSETTE |
062129 |
001 |
ANDA |
NYSTATIN |
NYSTATIN |
CREAM;TOPICAL |
100,000 UNITS/GM |
Prescription |
No |
No |
AT |
Approved Prior to Jan 1, 1982
|
FOUGERA PHARMS |
062225 |
001 |
ANDA |
NYSTATIN |
NYSTATIN |
CREAM;TOPICAL |
100,000 UNITS/GM |
Prescription |
No |
No |
AT |
Approved Prior to Jan 1, 1982
|
PADAGIS US |
062949 |
001 |
ANDA |
NYSTATIN |
NYSTATIN |
CREAM;TOPICAL |
100,000 UNITS/GM |
Prescription |
No |
No |
AT |
1988/06/13
|
ACTAVIS MID ATLANTIC |
064022 |
001 |
ANDA |
NYSTATIN |
NYSTATIN |
CREAM;TOPICAL |
100,000 UNITS/GM |
Prescription |
No |
Yes |
AT |
1993/01/29
|
TARO |
207733 |
001 |
ANDA |
NYSTATIN |
NYSTATIN |
CREAM;TOPICAL |
100,000 UNITS/GM |
Prescription |
No |
No |
AT |
2017/09/26
|
CROWN LABS INC |
212557 |
001 |
ANDA |
NYSTATIN |
NYSTATIN |
CREAM;TOPICAL |
100,000 UNITS/GM |
Prescription |
No |
No |
AT |
2019/07/24
|
TORRENT |
213566 |
001 |
ANDA |
NYSTATIN |
NYSTATIN |
CREAM;TOPICAL |
100,000 UNITS/GM |
Prescription |
No |
No |
AT |
2021/08/10
|
MACLEODS PHARMS LTD |